DK0565965T3 - Benzo(b)thiophen-5-yl-derivat og fremgangsmåde til fremstilling deraf - Google Patents

Benzo(b)thiophen-5-yl-derivat og fremgangsmåde til fremstilling deraf

Info

Publication number
DK0565965T3
DK0565965T3 DK93105441.5T DK93105441T DK0565965T3 DK 0565965 T3 DK0565965 T3 DK 0565965T3 DK 93105441 T DK93105441 T DK 93105441T DK 0565965 T3 DK0565965 T3 DK 0565965T3
Authority
DK
Denmark
Prior art keywords
benzo
protecting
thiophen
formula
optically active
Prior art date
Application number
DK93105441.5T
Other languages
English (en)
Inventor
Tetsuo Yamafuji
Hisaaki Chaki
Joji Nakano
Nobuhisa Taya
Kaishu Momonoi
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Application granted granted Critical
Publication of DK0565965T3 publication Critical patent/DK0565965T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
  • Furan Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Seasonings (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
DK93105441.5T 1992-04-13 1993-04-01 Benzo(b)thiophen-5-yl-derivat og fremgangsmåde til fremstilling deraf DK0565965T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP11974092 1992-04-13
JP5090934A JP2873898B2 (ja) 1992-04-13 1993-03-25 ベンゾ[b]チオフェン−5−イル誘導体もしくはその光学活性体またはそれらの塩並びにそれらの製造法

Publications (1)

Publication Number Publication Date
DK0565965T3 true DK0565965T3 (da) 1997-04-21

Family

ID=26432339

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93105441.5T DK0565965T3 (da) 1992-04-13 1993-04-01 Benzo(b)thiophen-5-yl-derivat og fremgangsmåde til fremstilling deraf

Country Status (19)

Country Link
US (1) US5380878A (da)
EP (1) EP0565965B1 (da)
JP (1) JP2873898B2 (da)
KR (1) KR960005955B1 (da)
AT (1) ATE145204T1 (da)
AU (1) AU643634B1 (da)
BE (1) BE1006403A3 (da)
CA (1) CA2093048C (da)
CZ (2) CZ290421B6 (da)
DE (1) DE69305904T2 (da)
DK (1) DK0565965T3 (da)
ES (1) ES2060545B1 (da)
FR (1) FR2689890B1 (da)
HU (1) HU213631B (da)
IT (1) IT1261440B (da)
NZ (1) NZ247301A (da)
PL (1) PL172191B1 (da)
RO (1) RO115445B1 (da)
TW (1) TW232690B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5606076A (en) * 1995-06-07 1997-02-25 Eli Lilly And Company Process for the synthesis of benzo[b]thiophenes
AU2576797A (en) * 1996-04-22 1997-11-12 Toyama Chemical Co. Ltd. Patch containing 1,2-ethanediol derivatives or salts thereof
JP4245668B2 (ja) * 1997-03-31 2009-03-25 富山化学工業株式会社 2−(ベンゾ〔b〕チオフェン−5−イル)−2−ヒドロキシ酢酸誘導体もしくはその光学活性体またはそれらの塩の製造法
PL196773B1 (pl) * 1999-06-11 2008-01-31 Toyama Chemical Co Ltd Pochodna N-alkiloksyalkilo-N,N-dialkiloaminy lub jej sole oraz środek zawierający ten związek stosowany do leczenia chorób neurodegeneratywnych
KR100710564B1 (ko) * 2003-07-30 2007-04-24 에스케이 주식회사 연속 모사 이동층 흡착분리공정을 이용한 광학활성티오펜계 화합물의 분리방법

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1981001408A1 (en) * 1979-11-15 1981-05-28 Sorex Ltd Substituted acetic acid esters as pesticides
EP0179383B1 (en) * 1984-10-25 1991-05-29 Hoechst-Roussel Pharmaceuticals Incorporated 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds, a process for their preparation and their use as medicaments
DK167393B1 (da) * 1985-12-30 1993-10-25 Roussel Uclaf 1-sulfonyl-2-oxo-pyrrolidinderivater, deres fremstilling og farmaceutiske praeparater med indhold deraf
IT1204494B (it) * 1986-03-28 1989-03-01 Roussel Maestretti Spa Derivati della 1-stirene solfonil 2-osso 5-alcossi pirrolidina,loro procedimento di preparazione e loro applicazione come farmaci
US4791107A (en) * 1986-07-16 1988-12-13 Hoechst-Roussel Pharmaceuticals, Inc. Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and) 1,3A,8)-di(and tri)methylpyrrolo(2,3-B)indoles, compositions and use
JPH0813741B2 (ja) * 1987-08-10 1996-02-14 協和醗酵工業株式会社 抗痴呆剤
US4877790A (en) * 1987-12-15 1989-10-31 Kanebo Limited Quinazoline derivative, processes for its production, and cerebral dysfunction remedying agent comprising it as active ingredient
US4859666A (en) * 1988-07-06 1989-08-22 Bristol-Myers Company THAZ derivatives for enhancement of cerebral function
JPH085790B2 (ja) * 1988-11-11 1996-01-24 杏林製薬株式会社 記憶障害改善薬
NZ232493A (en) * 1989-02-14 1992-06-25 Toyama Chemical Co Ltd Aryl- or heterocyclyl-substituted 1,2-ethanediol derivatives and pharmaceutical compositions
JP3044055B2 (ja) * 1990-08-09 2000-05-22 富山化学工業株式会社 1,2―エタンジオール誘導体およびその塩

Also Published As

Publication number Publication date
IT1261440B (it) 1996-05-23
FR2689890A1 (fr) 1993-10-15
BE1006403A3 (fr) 1994-08-16
HU213631B (en) 1997-08-28
CA2093048A1 (en) 1993-10-14
ATE145204T1 (de) 1996-11-15
CA2093048C (en) 1996-10-08
ES2060545A1 (es) 1994-11-16
DE69305904D1 (de) 1996-12-19
TW232690B (da) 1994-10-21
ITRM930232A1 (it) 1994-10-09
KR960005955B1 (ko) 1996-05-06
ITRM930232A0 (it) 1993-04-09
JP2873898B2 (ja) 1999-03-24
KR930021632A (ko) 1993-11-22
AU643634B1 (en) 1993-11-18
JPH069615A (ja) 1994-01-18
PL298494A1 (en) 1993-12-27
NZ247301A (en) 1994-07-26
FR2689890B1 (fr) 1995-01-06
EP0565965B1 (en) 1996-11-13
HUT64319A (en) 1993-12-28
HU9301052D0 (en) 1993-07-28
CZ290864B6 (cs) 2002-11-13
CZ290421B6 (cs) 2002-07-17
US5380878A (en) 1995-01-10
DE69305904T2 (de) 1997-03-13
CZ61093A3 (en) 1993-12-15
EP0565965A2 (en) 1993-10-20
EP0565965A3 (da) 1994-03-02
ES2060545B1 (es) 1997-12-01
PL172191B1 (pl) 1997-08-29
RO115445B1 (ro) 2000-02-28

Similar Documents

Publication Publication Date Title
ES8202546A1 (es) Metodo de producir derivados de tiazolidina
EE03194B1 (et) Ühendid, nende kasutamine magustavate toimeainetena ja nende valmistamise meetod
KR890008137A (ko) 3-[4(1-치환된-4-피페라지닐)부틸]-4-티아졸리디노 이의 제조방법 및 약제로서의 이의 용도
FI880742A (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten, 7-asemassa substituoitujen 19-norsteroidien valmistamiseksi
DK0565965T3 (da) Benzo(b)thiophen-5-yl-derivat og fremgangsmåde til fremstilling deraf
DK470181A (da) Fremgangsmaade til fremstilling af beta-lactamer
KR850004754A (ko) 3-인돌 카르복사미드 화합물류의 제조방법
FI102679B1 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten sertindoli-prodrugjohdannaisten valmistamiseksi
ES2147196T3 (es) Procedimiento para la hidrolisis estereoespecifica de derivados de piperidindiona.
DE69103087D1 (de) N-substituierte Trifluormethylphenyltetrahydropyridine, Verfahren zur Herstellung, Zwischenprodukte, sowie Arzneimittel, die solche enthalten.
PT87219A (pt) Process for preparing sulfonyldecahydro-8h-isoquino ]2,1-g" ]1,6" naphthyridines optical isomers thereof and related compounds
NO178025C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive (benzhydryloksyetylpiperidyl)alifatiske syrederivater
FI940999A0 (fi) Piperidin-2-alkyylikarboksylaattien entsymaattinen toisiintuminen ja saatujen yhdisteiden käyttö synteesin välituotteina
GB1433131A (en) Penicillins
FR2609603B1 (fr) Agents edulcorants derives des acides guanidinoacetique et ethanamidinoacetique, procede pour edulcorer des produits divers, et compositions contenant de tels agents edulcorants
FR2566405B1 (fr) Nouveaux derives de l'acide 4-hydroxy 3-quinoleine carboxylique substitues en 2 par une fonction aminee, leur preparation, leur application comme medicaments, les compositions les renfermant et les intermediaires nouveaux obtenus
DE69123009T2 (de) Verfahren zur Herstellung optisch aktiver 3-Hydroxybutan-Derivate
KR880008972A (ko) 카르복실산 유도체
DK0663901T3 (da) Fremgangsmåde til stereoselektiv fremstilling af et derivat af beta-phenylisoserin samt anvendelse deraf til fremstilling af taxanderivater
HU905000D0 (en) Process for producing compounds suitable for treatment of gastric ulcer
ATE384706T1 (de) Verfahren zur kontinuierlichen herstellung von substituierten oxazolen
DE3675424D1 (de) Valiolaminderivate und ihre herstellung.
DE69123402T2 (de) Verfahren zur Herstellung optisch aktiver Alpha-Hydroxyalkenderivate
FR2424247A2 (fr) Nouveaux derives d'acides arylalcanoiques a action hypolipemiante et leurs procedes d'obtention
HUT49838A (en) Process for producing optical isomers of 2-(3,4-disubstituted phenyl)-3-methylbutyric acids and their esters